PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

Cited by (889)

Items 501–600 of 889

1. IL-27 induces IFN/STAT1-dependent genes and enhances function of TIGIT+ HIVGag-specific T cells
   Jie Cheng, Timothy G. Myers, Callie Levinger, Princy N. Kumar, Jai Kumar, Bruktawit A. Goshu, Alberto Bosque, Marta Catálfamo · 2021 · iScience
2. Evolving Strategies to Eliminate the CD4 T Cells HIV Viral Reservoir via CAR T Cell Immunotherapy
   Jarrod York, Kavitha Gowrishankar, Kenneth P. Micklethwaite, Sarah Palmer, Anthony Lawrence Cunningham, Najla Nasr · 2022 · Frontiers in Immunology
3. PD ‐1 modulates steady‐state and infection‐induced IL ‐10 production in vivo
   Cortez McBerry, Alexandra Dias, Nathaniel Shryock, Kristin Lampe, Fredy R. S. Gutierrez, Louis Boon, De’Broski R. Herbert, Júlio Aliberti · 2013 · European Journal of Immunology
4. IL-17 and IL-22 production in HIV+ individuals with latent and active tuberculosis
   Kamakshi Prudhula Devalraju, Venkata Sanjeev Kumar Neela, Sharadambal Sunder Ramaseri, Arunabala Chaudhury, Abhinav Van, Siva Sai Krovvidi, Ramakrishna Vankayalapati, Vijaya Lakshmi Valluri · 2018 · BMC Infectious Diseases
5. PD-1 Expression in HIV-Specific CD8+ T cells Before Antiretroviral Therapy Is Associated With HIV Persistence
   Yanina Ghiglione, César Trifone, Jimena Salido, Ajantha Rhodes, María Julia Ruiz, María L. Polo, Horacio Salomón, Natalia Laufer, Omar Gustavo Sued, Sharon R. Lewin et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
6. Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck
   Anna D. Kosinska, Ejuan Zhang, Mengji Lu, Michael Roggendorf · 2010 · Hepatitis Research and Treatment
7. HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels
   Michael A. Eller, Marc Sam Opollo, Michelle Liu, Andrew D. Redd, Leigh Anne Eller, Cissy M Kityo, John Timothy Kayiwa, Oliver B Laeyendecker, Maria Joan Wawer, M. Milazzo et al. · 2014 · The Journal of Infectious Diseases
8. Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy
   Hongbing Yang, Tao Dong, Emma L. Turnbull, Srin Ranasinghe, Beatrice Ondondo, Nilu P Goonetilleke, Nicola Winstone, Kati di Gleria, Paul Bowness, Christopher P. Conlon et al. · 2007 · The Journal of Immunology
9. Negative Checkpoint Regulatory Molecule 2B4 (CD244) Upregulation Is Associated with Invariant Natural Killer T Cell Alterations and Human Immunodeficiency Virus Disease Progression
   Fareed Ahmad, Esaki Muthu Shankar, Yean Kong Yong, Hong Yien Tan, Gerrit Ahrenstorf, Roland Jacobs, Marie Larsson, Reinhold Ernst Schmidt, Adeeba Kamarulzaman, Abdul Wahid Ansari · 2017 · Frontiers in Immunology
10. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy
    Erin Beck, Irene C. M. Cortese · 2020 · Current Opinion in Virology
11. Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection
    Wei Li, Fahim Syed, Richard Yu, Jing Yang, Ying Xia, Ryan F. Relich, Patrick M. Russell, Shanxiang Zhang, Mandana Khalili, Laurence Huang et al. · 2022 · Frontiers in Immunology
12. PD-1 blockade: A promising immunotherapy for HIV?
    Bernard J. C. Macatangay, Charles R. Rinaldo · 2009 · PubMed
13. Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors
    Risa Omori, Junichi Eguchi, Kazumasa Hiroishi, S. Ishii, Ayako Hiraide, Masashi Sakaki, Hiroyoshi Doi, Atsushi Kajiwara, Takayoshi Ito, Mari Kogo et al. · 2012 · Cancer Gene Therapy
14. HLA-E–restricted CD8+ T Lymphocytes Efficiently Control Mycobacterium tuberculosis and HIV-1 Coinfection
    Marco Pio La Manna, Valentina Orlando, Teresa Prezzemolo, Paola Di Carlo, Antonio Cascio, Giovanni Delogu, Guido Poli, Lucy Catherine Sullivan, Andrëw G. Brööks, Francesco Dieli et al. · 2019 · American Journal of Respiratory Cell and Molecular Biology
15. A Participant-Derived Xenograft Model of HIV Enables Long-Term Evaluation of Autologous Immunotherapies
    Chase D. McCann, Christiaan Hendrik van Dorp, Ali Danesh, Adam R. Ward, Thomas R. Dilling, Talia M. Mota, Elizabeth A. Zale, Eva M. Stevenson, Shabnum Patel, Chanson J. Brumme et al. · 2020 · The Journal of Experimental Medicine
16. Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection
    Yuting Sun, Jing Xue · 2022 · Viruses
17. Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness
    Chun‐Pu Lin, Pierre L. Levy, Astrid Alflen, Georgi Apriamashvili, Maarten Alexander Ligtenberg, David W. Vredevoogd, Onno B. Bleijerveld, Ferhat Alkan, Yuval Malka, Liesbeth Hoekman et al. · 2024 · Cancer Cell
18. Hybrid spherical nucleotide nanoparticles can enhance the synergistic anti-tumor effect of CTLA-4 and PD-1 blockades
    Jing Zhang, Dan Liu, Jiale Liu, Yanfeng Han, Haiyan Xu, Xigang Leng, Deling Kong, Lanxia Liu · 2020 · Biomaterials Science
19. A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping
    José Ramón Vidal-Castiñeira, Antonio López‐Vázquez, Rebeca Alonso‐Arias, Marco Antonio Moro‐García, Pablo Martínez‐Camblor, Santiago Melón, Jesús Prìeto, Rosario López‐Rodríguez, Paloma Sanz-Cameno, Luı́s Rodrigo et al. · 2012 · Journal of Hepatology
20. Immunotherapy of Murine Retrovirus-Induced Acquired Immunodeficiency by CD4 T Regulatory Cell Depletion and PD-1 Blockade
    Wen Li, William R. Green · 2011 · Journal of Virology
21. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression
    Robert Paris, Constantinos Petrovas, Sara Ferrando‐Martínez, Eirini Moysi, Kristin L. Boswell, Eva J. Archer, Takuya Yamamoto, David R. Ambrozak, Joseph Paul Casazza, Richard Haubrich et al. · 2015 · PLoS ONE
22. Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8 + T Cells That Is Associated with Lower Viral Load
    José Peña, Norman G. Jones, Stephanie Bousheri, David R. Bangsberg, Huyen Cao · 2013 · AIDS Research and Human Retroviruses
23. HIV Suppression Restores the Lung Mucosal CD4+T-Cell Viral Immune Response and Resolves CD8+T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease
    Iulia Popescu, Michael Drummond, Lúcio Gama, Allison Lambert, Aki Hoji, Tiffany A. Coon, Christian A. Merlo, Robert A. Wise, Jeanne C. Keruly, Janice E. Clements et al. · 2016 · The Journal of Infectious Diseases
24. Immune Checkpoint Inhibitors in Melanoma and HIV Infection
    Antonio Marra, Giosuè Scognamiglio, Ilaria Peluso, Gerardo Botti, Celeste Fusciello, Amelia Filippelli, Paolo A. Ascierto, Stefano Pepe, Francesco Sabbatino · 2017 · The Open AIDS Journal
25. Visualizing the Immune System: Providing Key Insights into HIV/SIV Infections
    Jacob D. Estes, Roger Le Grand, Constantinos Petrovas · 2018 · Frontiers in Immunology
26. Alveolar Macrophage Dysfunction and Increased PD-1 Expression During Chronic SIV Infection of Rhesus Macaques
    Ruth Hunegnaw, Zuena Mushtaq, Gospel M Enyindah-Asonye, Tanya N. Hoang, Marjorie Robert-Guroff · 2019 · Frontiers in Immunology
27. Monocyte‐mediated T cell suppression by HIV‐2 envelope proteins
    Rita Cavaleiro, Gregory J. Brunn, Adriana S. Albuquerque, Rui M. M. Victorino, Jeffrey L. Platt, Ana E. Sousa · 2007 · European Journal of Immunology
28. Human Immunodeficiency Virus Type 1 Escapes from Interleukin-2-Producing CD4 + T-Cell Responses without High-Frequency Fixation of Mutations
    Richard Brad Jones, FengYun Yue, Xiao Xiao Jenny Gu, Diana V. Hunter, Shariq Mujib, Gabor T. Gyenes, Rosemarie D. Mason, Ruqaya Mohamed, Kelly S. MacDonald, Colin M Kovacs et al. · 2009 · Journal of Virology
29. Unraveling the Role of PD-1/PD-L Interactions in Persistent Hepatotropic Infections: Potential for Therapeutic Application?
    Henry Radziewicz, Holly L. Hanson, Rafi Ahmed, Arash Grakoui · 2008 · Gastroenterology
30. Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms
    Steven De Almeida, Mathilde Regimbeau, G. Jego, C. Garrido, F. Girodon, F. Hermetet · 2020 · Cancers
31. Dissecting the Requirements for Maintenance of the CMV-Specific Memory T-Cell Pool
    Andrea I. Loewendorf, Ramon Arens, Jared F. Purton, Charles D. Surh, Chris A. Benedict · 2011 · Viral Immunology
32. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia
    Rita Tendeiro Rego, Russell B. Foxall, António P. Baptista, Francisco Rodrigues Pinto, Rui Silva Soares, Rita Cavaleiro, Emília Valadas, Perpétua Gómes, Rui M. M. Victorino, Ana E. Sousa · 2012 · AIDS
33. Human Immunodeficiency Virus-Infected Women Have High Numbers of CD103−CD8+ T Cells Residing Close to the Basal Membrane of the Ectocervical Epithelium
    Anna Gibbs, Marcus Buggert, Gabriella Edfeldt, Petter Ranefall, Andrea Introini, Stanley Cheuk, Elisa Martini, Liv Eidsmo, Terry Blake Ball, Joshua Kimani et al. · 2017 · The Journal of Infectious Diseases
34. Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
    Selena Viganó, Sara Bobisse, George Coukos, Matthieu Perreau, Alexandre Harari · 2020 · Frontiers in Immunology
35. A Peptide-Based Checkpoint Immunomodulator Alleviates Immune Dysfunction in Murine Polymicrobial Sepsis
    Timothy W. Phares, Vinayaka Kotraiah, Chun‐Shiang Chung, Jacqueline Unsinger, Monty B. Mazer, Kenneth E. Remy, Cecille D. Browne, Peter J. Buontempo, Marc Mansour, James Pannucci et al. · 2020 · Shock
36. Finding Balance: T cell Regulatory Receptor Expression during Aging.
    Mary Cavanagh, Qian Qi, Cornelia M. Weyand, Jörg J. Goronzy · 2011 · Europe PMC (PubMed Central)
37. Impact of γ‐chain cytokines on T cell homeostasis in HIV‐1 infection: therapeutic implications
    Marie‐Lise Gougeon, Francesca Chiodi · 2010 · Journal of Internal Medicine
38. Glucocorticoid‐Induced Tumor Necrosis Factor Receptor Family–Related Protein Triggering Enhances HIV‐Specific CD4+T Cell Cytokine Secretion and Protects HIV‐Specific CD4+T Cells from Apoptosis
    Timothy Lahey, Suzanne D. Loisel, Wendy Wieland‐Alter · 2007 · The Journal of Infectious Diseases
39. Herpesvirus Exploitation of Host Immune Inhibitory Pathways
    Gabrielle Stack, Maria A. Stacey, Ian Robert Humphreys · 2012 · Viruses
40. Quis Custodiet Ipsos Custodes? Regulation of Cell-Mediated Immune Responses Following Viral Lung Infections
    Meredith C. Rogers, John V. Williams · 2018 · Annual Review of Virology
41. Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2
    Vaishnavi Srinivasan Iyer, Sanjaykumar V. Boddul, Anna‐Karin Johnsson, Bruno Raposo, Ravi Kumar Sharma, Yunbing Shen, Zsolt Kasza, Kah Wai Lim, Karine Chemin, Gunnar P. Nilsson et al. · 2022 · Journal of Autoimmunity
42. PD-L1/BTLA Checkpoint Axis Exploited for Bacterial Immune Escape by Restraining CD8+ T Cell–Initiated Adaptive Immunity in Zebrafish
    Chongbin Hu, Chen Huang, Jie Wang, Yun Mi Hong, Dongdong Fan, Ye Chen, Aifu Lin, Li‐xin Xiang, Jian-zhong Shao · 2023 · The Journal of Immunology
43. Programmed Death-1 & its Ligands: Promising Targets for Cancer Immunotherapy
    Rajeev Kumar Shrimali, John Edward Janik, Rasha Abu Eid, Mikayel Mkrtichyan, Samir N. Khleif · 2015 · Immunotherapy
44. Molecular mechanisms of HBeAg in persistent HBV infection
    Limin Chen, Xuegong Fan, Jing Ma, Bo He, Yongfang Jiang · 2016 · Hepatology International
45. Pre-existing Simian Immunodeficiency Virus Infection Increases Expression of T Cell Markers Associated with Activation during Early Mycobacterium tuberculosis Coinfection and Impairs TNF Responses in Granulomas
    Erica C. Larson, Amy L. Ellis-Connell, Mark Rodgers, Alexis J. Balgeman, Ryan V. Moriarty, Cassaundra L. Ameel, Tonilynn Baranowski, Jaime A. Tomko, Chelsea M. Causgrove, Pauline A Maiello et al. · 2021 · The Journal of Immunology
46. Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections
    Lydie Trautmann, Elias Anthony Said, Rabih Halwani, Loury Janbazian, Nicolas Chomont, Mohamed El Far, Gaëlle Breton, Elias K. Haddad, Rafick‐Pierre Sékaly · 2007 · Current Opinion in HIV and AIDS
47. Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C
    Andrea Crosignani · 2016 · World Journal of Gastroenterology
48. CD3ε Expression Defines Functionally Distinct Subsets of Vδ1 T Cells in Patients With Human Immunodeficiency Virus Infection
    Pádraic J. Dunne, Christina O. Maher, Michael Freeley, Katie Dunne, Andreea Petrasca, Judy Orikiiriza, Margaret R. Dunne, Derval Reidy, Siobhán O’Dea, Aisling Loy et al. · 2018 · Frontiers in Immunology
49. Dominant Human CD8 T Cell Clonotypes Persist Simultaneously as Memory and Effector Cells in Memory Phase
    Cédric Touvrey, Laurent Derré, Estelle Devêvre, Patricia Corthésy, Pedro J. Romero, Nathalie Rufer, Daniel E. Speiser · 2009 · The Journal of Immunology
50. Prime-boost immunization strategies against HIV-1
    Andreas Bråve · 2007 · Figshare
51. CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data
    Jianming Tang, Xuelin Li, Matt A. Price, Eduard Joachim Sanders, Omu Aggrey Anzala, Etienne Karita, Anatoli Kamali, Shabir Lakhi, Susan A Allen, Eric Hunter et al. · 2015 · Frontiers in Microbiology
52. Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody
    Amir A. Al-Khami, Sawsan Youssef, Yasmina Noubia Abdiche, HoangKim T. Nguyen, Joyce Chou, Christopher R. Kimberlin, Sherman Michael Chin, Cris Kamperschroer, Bart A. Jessen, Brent Kern et al. · 2020 · Molecular Cancer Therapeutics
53. Immune Checkpoint Molecules and Glucose Metabolism in HIV-Induced T Cell Exhaustion
    Yee Teng Chan, Heng Choon Cheong, Ting Fang Tang, Reena Rajasuriar, Kian‐Kai Cheng, Chung Yeng Looi, Won Fen Wong, Adeeba Kamarulzaman · 2022 · Biomedicines
54. EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypes
    Andrea Gramatica, Itzayana G. Miller, Adam R. Ward, Khan Farzana, Tyler J. Kemmer, Jared Weiler, Tan Thinh Huynh, Paul Zumbo, Andrew P. Kurland, Louise Leyre et al. · 2025 · Cell Reports
55. The Programmed Death (PD)‐1/PD‐Ligand 1 Pathway Regulates Graft‐Versus‐Host‐Reactive CD8 T Cells After Liver Transplantation
    Marcus Schuchmann, Ralf Georg Meyer, E. Distler, Esther von Stebut, Jurgen H. E. Kuball, Elke Schnürer, Thomas Wölfel, M. Theobald, Abdo Konur, Sabrina Gregor et al. · 2008 · American Journal of Transplantation
56. Innate IFN-γ Is Essential for Programmed Death Ligand-1–Mediated T Cell Stimulation following Listeria monocytogenes Infection
    Jared H. Rowe, James M. Ertelt, Sing Sing Way · 2012 · The Journal of Immunology
57. Enhanced PD-1 Expression by T Cells in Cerebrospinal Fluid Does Not Reflect Functional Exhaustion during Chronic Human Immunodeficiency Virus Type 1 Infection
    Shanmugalakshmi Sadagopal, Shelly L. Lorey, Louise D. Barnett, Deborah Sutherland, Rebecca Basham, Husamettin Erdem, Spyros A. Kalams, David W. Haas · 2009 · Journal of Virology
58. Targeting PD-1 in cancer: Biological insights with a focus on breast cancer
    Cinzia Solinas, Marco Maria Aiello, Pushpamali De Silva, Chunyan Gu‐Trantien, Edoardo Migliori, Karen E Willard-Gallo · 2019 · Critical Reviews in Oncology/Hematology
59. T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals
    Stefano Rinaldi, Lesley R. de Armas, Sara Domínguez‐Rodríguez, Suresh Pallikkuth, Vinh B. Dinh, Li Pan, Kathleen Gärtner, Rajendra Pahwa, Nicola Cotugno, Pablo Rojo et al. · 2021 · PLoS Pathogens
60. Upregulation of Interleukin 7 Receptor Alpha and Programmed Death 1 Marks an Epitope-Specific CD8+T-Cell Response That Disappears following Primary Epstein-Barr Virus Infection
    Delphine Sauce, Martin Larsen, Rachel J.M. Abbott, Andrew D. Hislop, Alison M. Leese, Naeem Khan, Laura Papagno, Gordon James Freeman, Alan B. Rickinson · 2009 · Journal of Virology
61. HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths
    Shabnum Patel, Elizabeth A. Chorvinsky, Shuroug Albihani, Carolina Colli Cruz, Richard Brad Jones, Elizabeth J. Shpall, David M. Margolis, Richard F. Ambinder, Catherine M. Bollard · 2018 · Molecular Therapy
62. HIV specific CD8+ TRM-like cells in tonsils express exhaustive signatures in the absence of natural HIV control
    Rabiah Fardoos, Sarah K. Nyquist, Osaretin Emmanuel Asowata, Samuel W. Kazer, Alveera Singh, Abigail Ngoepe, Jennifer Giandhari, Ntombifuthi Mthabela, Dirhona Ramjit, Samita Singh et al. · 2022 · Frontiers in Immunology
63. Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells in vivo
    Hanyu Pan, Xinyi Yang, Jing Wang, Huitong Liang, Zhengtao Jiang, Lin Zhao, Yanan Wang, Zhiming Liang, Xiaoting Shen, Qinru Lin et al. · 2023 · Virologica Sinica
64. Inverse association of repressor growth factor independent-1 with CD8 T cell interleukin (IL)-7 receptor α expression and limited signal transducers and activators of transcription signaling in response to IL-7 among γ-chain cytokines in HIV patients
    Anita C. Benoit, Khaled Abdkader, Danylo Sirskyj, Abdulkarim Alhetheel, Nadia Sant, Francisco Díaz‐Mitoma, Ashok Kumar, Marko Kryworuchko · 2009 · AIDS
65. Early Virus-Associated Bystander Events Affect the Fitness of the CD8 T Cell Response to Persistent Virus Infection
    Nicolas P. Andrews, Christopher D. Pack, Vaiva Vezys, Glen N. Barber, Aron E. Lukacher · 2007 · The Journal of Immunology
66. Increased levels of PD ‐1 expression on CD 8 T cells in patients post‐renal transplant irrespective of chronic high EBV viral load
    Julie Moran, Jonathan Dean, Andre De Oliveira, Marie O’Connell, Michael Riordan, Jeff Connell, Atif Awan, William W. Hall, Jaythoon Hassan · 2013 · Pediatric Transplantation
67. CD4 T-Cell Help Programs a Change in CD8 T-Cell Function Enabling Effective Long-Term Control of Murine Gammaherpesvirus 68: Role of PD-1-PD-L1 Interactions
    Peter B. Dias, Francesca Giannoni, Lian Ni Lee, Dongun Han, Sorah Yoon, Hideo Yagita∥, Miyuki Azuma, Sally R. Sarawar · 2010 · Journal of Virology
68. Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification
    Henning Lauterbach, Phi Truong, Dorian B. McGavern · 2007 · Virology Journal
69. On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
    Benjamin Y. Kong, Holly A. Bolton, Julius W. Kim, Pablo A. Silveira, Phillip D. Fromm, Georgina Jane Clark · 2019 · Frontiers in Oncology
70. Chapter 9 HIV Induced AIDS and Related Cancers
    Martin Cadogan, Angus George Dalgleish · 2008 · Advances in cancer research
71. Why cure, why now?
    Daniel R. Kuritzkes · 2016 · Journal of Medical Ethics
72. Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
    Anna M. Timofeeva, Sergey E. Sedykh, Georgy A. Nevinsky · 2022 · Vaccines
73. HIV cure strategies: which ones are appropriate for Africa?
    Christopher Zaab-Yen Abana, Helena Lamptey, Evelyn Yayra Bonney, George B. Kyei · 2022 · Cellular and Molecular Life Sciences
74. New approaches to design HIV-1 T-cell vaccines
    Hélène Perrin, Glenda Canderan, Rafick‐Pierre Sékaly, Lydie Trautmann · 2010 · Current Opinion in HIV and AIDS
75. MicroRNA-138 Regulates T-Cell Function by Targeting PD-1 in Patients with Hepatitis B Virus–Related Liver Diseases
    Wei Liu, Xianzhao Zheng, Jie Wang, Quanli He, Junmin Li, Zengzeng Zhang, Hongchun Liu · 2020 · Laboratory Medicine
76. Cytometry, immunology, and HIV infection: Three decades of strong interactions
    Andrea Cossarizza, Sara De Biasi, Lara Gibellini, Elena Bianchini, Regina Bartolomeo, Milena Nasi, Cristina Mussini, Marcello Pinti · 2013 · Cytometry Part A
77. Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?
    Mohamad Saifudin Hakim, Michelle Spaan, Harry L.A. Janssen, André Boonstra · 2013 · Reviews in Medical Virology
78. Sanctuaire du virus de l’immunodéficience humaine et mécanismes d’échappement
    Jérôme Estaquier, Bruno Hurtrel · 2008 · médecine/sciences
79. Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells
    Xue-Song Liang · 2010 · World Journal of Gastroenterology
80. Anti‐HIV adaptive immunity: determinants for viral persistence
    Hiroyuki Yamamoto, Tetsuro Matano · 2008 · Reviews in Medical Virology
81. The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
    Kathy A. Green, Taku Okazaki, Tasuku Honjo, W. James Cook, William R. Green · 2007 · Journal of Virology
82. Human Immunodeficiency Virus
    John Guatelli, Robert F. Siliciano, Daniel R. Kuritzkes, Douglas D. Richman · 2016 · ASM Press eBooks
83. Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load
    Henrik N. Kløverpris, Reuben McGregor, James E. McLaren, Kristin Ladell, Anette Stryhn, Catherine Kegakilwe Koofhethile, Jacqui Brener, Fabian Chen, Lynn Riddell, Luzzi Graziano et al. · 2014 · AIDS
84. Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA
    Cynthia Lungu, Riddhima Banga, Rob A. Gruters, Francesco A. Procopio · 2021 · Frontiers in Microbiology
85. The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors
    Elizabeth G. Hunt, Alex M. Andrews, Sydney R. Larsen, Jessica E. Thaxton · 2022 · Frontiers in Cell and Developmental Biology
86. SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)
    Yulia Alexandrova, Alexis Yero, Ralph‐Sydney Mboumba Bouassa, Eve Comeau, Suzanne Samarani, Zabrina L. Brumme, Mark Hull, Angela M. Crawley, Marc‐André Langlois, Jonathan Benjamin Angel et al. · 2023 · Viruses
87. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4+ T cell loss rates in human immunodeficiency virus-1 infection
    Frank Olav Pettersen, Kjetil Taskén, Dag Kvale · 2010 · Clinical & Experimental Immunology
88. Beyond IL-17: new cytokines in the pathogenesis of HIV infection
    Mario Clerici · 2010 · Current Opinion in HIV and AIDS
89. Functional Impairment of Central Memory CD4 T Cells Is a Potential Early Prognostic Marker for Changing Viral Load in SHIV-Infected Rhesus Macaques
    Hong He, Pramod N. Nehete, Bharti N. Nehete, Eric Wieder, Guojun Yang, Stephanie J. Buchl, K. Jagannadha Sastry · 2011 · PLoS ONE
90. Macaque Long-Term Nonprogressors Resist Superinfection with Multiple CD8 + T Cell Escape Variants of Simian Immunodeficiency Virus
    Jason T. Weinfurter, Gemma E. May, Taeko Soma, Ann Jones Hessell, Enrique J. León, Caitlin E. MacNair, Shari M. Piaskowski, Kim L. Weisgrau, Jessica R. Furlott, Nicholas J. Maness et al. · 2010 · Journal of Virology
91. Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine
    Vedran Brezar, Lylia Hani, Mathieu Surénaud, Audrey Hubert, Christine Lacabaratz, Jean‐Daniel Lelièvre, Yves Lévy, Nabila Seddiki · 2017 · PLoS Pathogens
92. The Inhibitory Co-Receptors: A Way to Save from Anergy the HIVSpecific T Cells
    Rita Simone, Gabriella Piatti, Danièle Saverino · 2009 · Current HIV Research
93. Expression of programmed cell death protein 1 and T‐cell immunoglobulin‐ and mucin‐domain‐containing molecule‐3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus
    Kamila Caraballo Cortés, Sylwia Osuch, Karol Perlejewski, Agnieszka Pawełczyk, Justyna Kaźmierczak, Maciej Janiak, Joanna Jabłońska, Khalil Nazzal, Anna Stelmaszczyk‐Emmel, Hanna Berak et al. · 2019 · Journal of Viral Hepatitis
94. Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
    Yiru Long, Xiaolu Yu, Runqiu Chen, Yongliang Tong, Likun Gong · 2022 · Frontiers in Immunology
95. Possibility of PD-1/PD-L1 Inhibitors for the Treatment of Patients with Chronic Hepatitis B Infection
    Menghan Su, Ting Ye, Wei Wu, Zheyue Shu, Qi Xia · 2023 · Digestive Diseases
96. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine
    Anna López, Nils van der Lubbe, Sonsoles Sánchez‐Palomino, Mireia Arnedo, Meritxell Nomdedéu, Pedro Castro, Meritxell Guilà, María José Maleno, Felipe García, Teresa Gallart et al. · 2009 · Vaccine
97. Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill
    Jan Kristoff, Charles R. Rinaldo, Robbie B. Mailliard · 2019 · Viruses
98. Generation of NO by Bystander Human CD8 T Cells Augments Allogeneic Responses by Inhibiting Cytokine Deprivation-Induced Cell Death
    Jonathan C. Choy, Jordan S. Pober · 2009 · American Journal of Transplantation
99. The role of T cell immunity in HIV-1 infection
    Cynthia Mee Ling Munier, Anthony Dominic Kelleher, Stephen John Kent, Robert De Rose · 2013 · Current Opinion in Virology
100. Rapid development of HIV elite control in a patient with acute infection
     Deirdre Morley, John Shearer Lambert, Louise E. Hogan, Cillian F De Gascun, Niamh Redmond, Rachel Lena Rutishauser, Cassandra Thanh, Erica A. Gibson, Kristen S. Hobbs, Sonia Bakkour et al. · 2019 · BMC Infectious Diseases